Please try another search
By Ludwig Burger FRANKFURT (Reuters) -Novartis reported a 6% gain in adjusted net income on Wednesday that fell short of the market view, as corporate expenses surpassed expectations built up by a...
(Reuters) - Sanofi (EPA:SASY) on Friday mapped out a potential separate listing of its consumer healthcare business from the fourth quarter of next year, as it plans to shore up new drug development...
Equity research firm Jefferies initiated coverage on BeiGene (NASDAQ:BGNE) with a "buy" rating and a price target of $287. BeiGene is an oncology company with a strong presence in China, and...
Investing.com - European stock markets drifted lower Tuesday, with losses in the banking sector weighing ahead of the start of big tech earnings season on Wall Street. At 04:05 ET (08:05 GMT), the DAX...
By Scott Kanowsky Investing.com -- Shares in Novartis AG (SIX:NOVN) saw their biggest intraday climb in fifteen months on Monday after the pharmaceutical giant announced positive results from a...
By Scott Kanowsky Investing.com -- European equities held steady near the flatline on Wednesday, as investors awaited the highly anticipated release of the Federal Reserve's latest interest rate...
By Scott Kanowsky Investing.com -- Novartis AG (SIX:NOVN) has confirmed that the Swiss competition commission (COMCO) has visited the Basel headquarters of the drugmaker in connection to an...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review